Skip to main content

Duration of Use Among New Users of Hydrochlorothiazide (HCTZ), Angiotensin-Converting Enzyme Inhibitors (ACEIs), and Angiotensin II Receptor Blockers (ARBs)

    Basic Details
    Date Posted
    Medical Product
    angiotensin II receptor blocker (ARB)
    angiotensin-converting enzyme (ACE) inhibitor
    hydrochlorothiazide (HCTZ)

    This report contains estimates of hydrochlorothiazide (HCTZ), angiotensin-converting enzyme inhibitor (ACEI), and angiotensin II receptor blocker (ARB) utilization in the Sentinel Distributed Database (SDD). Data from January 1, 2000 to June 30, 2018 from 17 Data Partners contributing to the SDD were included in this report. This request was distributed to Data Partners on August 20, 2018.

    Additional Details
    FDA Center
    Time Period
    January 1, 2000 - June 30, 2018
    Analysis Type
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)